Sirolimus Is Associated With Reduced Islet Engraftment and Impaired β-Cell Function
暂无分享,去创建一个
N. Zhang | R. Bottino | Jing Xu | J. Bromberg | H. H. Dong | S. Qu | A. Balamurugan | D. Su | T. Tse | Jing Xu | Henry Dong
[1] R. Bottino,et al. Therapeutic Angiogenesis for Islet Revascularization , 2006 .
[2] D. Stolz,et al. Harmful Delayed Effects of Exogenous Isolation Enzymes on Isolated Human Islets: Relevance to Clinical Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] S. di Paolo,et al. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. , 2005, Journal of the American Society of Nephrology : JASN.
[4] A. Shapiro,et al. Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.
[5] J. Schrezenmeir,et al. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.
[6] R. Nagai,et al. Potent Inhibitory Effect of Sirolimus on Circulating Vascular Progenitor Cells , 2005, Circulation.
[7] A. Shapiro,et al. The Portal Immunosuppressive Storm: Relevance to Islet Transplantation? , 2005, Therapeutic drug monitoring.
[8] A. Trapp,et al. The Impact of Immunosuppression on Endothelial Function , 2005, Journal of cardiovascular pharmacology.
[9] S. Schaffellner,et al. Dyslipidemia during sirolimus therapy in patients after liver transplantation , 2004, Clinical transplantation.
[10] J. Xu,et al. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. , 2004, The Journal of clinical investigation.
[11] U. Gehling,et al. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. , 2004, Experimental cell research.
[12] Marcela Brissova,et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. , 2004, Diabetes.
[13] N. Zhang,et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. , 2004, Diabetes.
[14] D. Melloul. Transcription Factors in Islet Development and Physiology: Role of PDX‐1 in Beta‐Cell Function , 2004, Annals of the New York Academy of Sciences.
[15] G. Mattsson,et al. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. , 2004, Diabetes.
[16] G. Koehl,et al. Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer , 2004, Clinical Cancer Research.
[17] A. F. Stewart,et al. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. , 2004, Endocrinology.
[18] Z. Bloomgarden,et al. Angiogenic gene therapy for improving islet graft vascularization , 2004 .
[19] A. Shapiro,et al. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. , 2004, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.
[20] B. Wolf,et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? , 2003, Transplantation.
[21] B. Wolf,et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. , 2003, Diabetes.
[22] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[23] S. Chueh,et al. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine–based immunosuppressive regimen: incidence, risk factors, progression, and prognosis1 , 2003, Transplantation.
[24] H. Hammes,et al. Angiogenic capacity of endothelial cells in islets of Langerhans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] R. Kirken,et al. Molecular actions of sirolimus: sirolimus and mTor. , 2003, Transplantation proceedings.
[26] B. Hering,et al. Sirolimus and islet transplants. , 2003, Transplantation proceedings.
[27] E. Schiff,et al. A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[28] G. Mattsson,et al. Impaired revascularization of transplanted mouse pancreatic islets is chronic and glucose-independent1 , 2003, Transplantation.
[29] J. Shapiro. Eighty years after insulin: parallels with modern islet transplantation. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[30] A. Shapiro,et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. , 2002, Diabetes.
[31] P. Carlsson,et al. Graft vascular function after transplantation of pancreatic islets , 2002, Diabetologia.
[32] G. Mattsson,et al. Decreased vascular density in mouse pancreatic islets after transplantation. , 2002, Diabetes.
[33] G. Koehl,et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor , 2002, Nature Medicine.
[34] M. Menger,et al. Revascularization and Microcirculation of Freely Grafted Islets of Langerhans , 2001, World Journal of Surgery.
[35] C. Ricordi,et al. Human Islet Transplantation: Update , 2001, World Journal of Surgery.
[36] P. Liss,et al. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. , 2001, Diabetes.
[37] R. Burcelin,et al. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. , 2000, Diabetes.
[38] P. Liss,et al. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. , 2000, Transplantation.
[39] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .
[40] J. Li,et al. Alpha-Gal oligosaccharides: chemistry and potential biomedical application. , 1999, Current medicinal chemistry.
[41] M. Menger,et al. Effects of cyclosporine A on the process of vascularization of freely transplanted islets of Langerhans , 1999, Journal of Molecular Medicine.
[42] K. Messmer,et al. Orientation of microvascular blood flow in pancreatic islet isografts. , 1994, The Journal of clinical investigation.
[43] S. Lenzen,et al. Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells. , 1991, The Biochemical journal.
[44] K. Messmer,et al. The influence of cyclosporine on the microvasculature of xenogeneic pancreatic islet grafts. , 1991, Transplantation proceedings.
[45] C. Newgard,et al. Glucokinase and glucose transporter expression in liver and islets: implications for control of glucose homoeostasis. , 1990, Biochemical Society transactions.
[46] K. Messmer,et al. The influence of prednisolone on revascularization of pancreatic islet grafts. , 1990, Transplantation proceedings.
[47] A. Secchi,et al. Islet-cell Transplantation , 1975, The Lancet.